The article discusses antivenoms for spider, scorpion, and snake bites that may be approved by the U.S. Food and Drug Administration, focusing on an antivenom developed at the University of Mexico, the pharmaceutical company Merck, and the treatment of black widow spider bites.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados